Expansion Opportunity OMNY Health has a broad national footprint spanning all fifty states with partnerships across specialty health networks, healthcare systems, academic medical centers, and integrated delivery networks. This presents a strong upsell path for additional data collaboration, analytics services, and expanded oncology and real-world evidence offerings to existing partners and affiliates.

Oncology Focus The May 2026 launch of an oncology product suite to address real-world evidence gaps signals a strategic push into cancer care analytics. Sales opportunities exist to cross-sell oncology specific data modules, AI-driven insights, and RWE studies to hospitals, cancer centers, and pharma sponsors looking for actionable tumor and treatment outcome data.

AI and Data Partnerships OMNY Health has demonstrated AI capabilities and data partnerships, including past work with AI platforms and collaborations with Datavant and AWS Clean Rooms. This opens doors for selling data collaboration agreements, secure data sharing, and co-developed AI analytics solutions for life sciences customers seeking compliant, large-scale real-world data access.

Clinical Information Management Recent recognition for Clinical Information Management and participation in prestigious innovation awards enhances credibility with enterprise buyers. This can be leveraged to position OMNY Health as a trusted partner for healthcare systems and providers seeking improve data governance, interoperability, and outcomes-focused reporting.

Financial and Scale Signals Current revenue range ($10M–$25M) and a sizable provider network (6.5 billion notes, 200+ specialties, 770,000+ providers) indicate a scalable data ecosystem. Opportunities exist to upsell higher-tier data access, premium analytics, and targeted real-world evidence studies to pharma, device manufacturers, and CROs seeking expansive datasets and robust analytics.